IQVIA HOLDINGS INC (QTS.DE) Stock Price, Forecast & Analysis
Europe - Frankfurt Stock Exchange - FRA:QTS - US46266C1053 - Common Stock
QTS.DE Key Statistics, Chart & Performance
The current stock price of QTS.DE is 192.95 EUR. In the past month the price increased by 9.91%.
QTS.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| DIM.PA | SARTORIUS STEDIM BIOTECH | 44.08 | 18.49B | ||
| 56S1.DE | SARTORIUS STEDIM BIOTECH | 43.97 | 18.44B | ||
| SRT3.DE | SARTORIUS AG-VORZUG | 49.3 | 16.83B | ||
| SRT.DE | SARTORIUS AG | 38.86 | 13.27B | ||
| QIA.DE | QIAGEN N.V. | 19.6 | 8.76B | ||
| 1SXP.DE | SCHOTT PHARMA AG& CO KGAA | 19.01 | 2.78B | ||
| EVT.DE | EVOTEC SE | N/A | 1.85B | ||
| GXI.DE | GERRESHEIMER AG | 6.38 | 813.76M | ||
| FF.MI | FINE FOODS & PHARMACEUTICALS | 10.13 | 198.98M |
Related stock screener links
About QTS.DE
Company Profile
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. The company is headquartered in Durham, North Carolina and currently employs 90,000 full-time employees. The company went IPO on 2013-05-09. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
Company Info
IQVIA HOLDINGS INC
2400 Ellis Road
Durham NORTH CAROLINA US
Employees: 88000
Phone: 19199982000
IQVIA HOLDINGS INC / QTS.DE FAQ
What does IQVIA HOLDINGS INC do?
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. The company is headquartered in Durham, North Carolina and currently employs 90,000 full-time employees. The company went IPO on 2013-05-09. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
Can you provide the latest stock price for IQVIA HOLDINGS INC?
The current stock price of QTS.DE is 192.95 EUR. The price increased by 1.82% in the last trading session.
Does QTS stock pay dividends?
QTS.DE does not pay a dividend.
What is the ChartMill technical and fundamental rating of QTS stock?
QTS.DE has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is the Price/Earnings (PE) ratio of IQVIA HOLDINGS INC (QTS.DE)?
The PE ratio for IQVIA HOLDINGS INC (QTS.DE) is 19.1. This is based on the reported non-GAAP earnings per share of 10.1 and the current share price of 192.95 EUR.
Is IQVIA HOLDINGS INC (QTS.DE) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on QTS.DE.
What is the market capitalization of QTS stock?
IQVIA HOLDINGS INC (QTS.DE) has a market capitalization of 32.80B EUR. This makes QTS.DE a Large Cap stock.
QTS.DE Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to QTS.DE.
QTS.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to QTS.DE. QTS.DE has a medium profitability rating, but doesn't score so well on its financial health evaluation.
QTS.DE Financial Highlights
Over the last trailing twelve months QTS.DE reported a non-GAAP Earnings per Share(EPS) of 10.1. The EPS increased by 7.09% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.07% | ||
| ROA | 4.47% | ||
| ROE | 20.83% | ||
| Debt/Equity | 2.08 |
QTS.DE Forecast & Estimates
29 analysts have analysed QTS.DE and the average price target is 196.08 EUR. This implies a price increase of 1.62% is expected in the next year compared to the current price of 192.95.
For the next year, analysts expect an EPS growth of 7.83% and a revenue growth 5.27% for QTS.DE